Amazon Omics gives life sciences teams a more scalable way to store, process, and analyze omics data in AWS. For organizations working across genomics, transcriptomics, and multimodal research, it can reduce workflow complexity while improving collaboration, governance, and cloud readiness.
In this on-demand webinar, PTP explains why Amazon Omics matters for life sciences organizations, how it fits into existing AWS environments, and what teams should evaluate before getting started.
Key takeaways
- Amazon Omics was built to help life sciences teams manage and analyze growing omics data in a more scalable, AWS-native way.
- The service supports sequence storage, reference and sequence stores, bioinformatics workflows, variant and annotation data, and multimodal analysis.
- Teams can connect Amazon Omics to broader AWS services for storage, access control, analytics, and machine learning.
- AWS-native architecture can improve cost control, governance, and security compared with more fragmented platform approaches.
- Successful adoption depends on aligning research needs, data workflows, compliance expectations, and cloud architecture early.
Why AWS built Amazon Omics
Many biotech and life sciences organizations still struggle with fragmented lab systems, siloed research data, and disconnected bioinformatics workflows. Those challenges slow collaboration, make it harder to build usable data lakes, and create unnecessary operational work for scientific and IT teams.
Amazon Omics was introduced to help address those problems with managed capabilities designed for omics data storage, workflow execution, and downstream analysis. Instead of forcing teams to piece together every layer manually, it provides a more structured way to support scalable research infrastructure in AWS.
What Amazon Omics includes
Amazon Omics supports multiple layers of the omics data lifecycle, from storage and workflow orchestration to variant and annotation analysis. It is designed to help teams work across genomic, transcriptomic, and other multi-omic data types while keeping those workflows closer to the rest of their AWS environment.
How Amazon Omics fits into the broader AWS environment
One of the biggest advantages of Amazon Omics is that it fits naturally into the broader AWS ecosystem. Life sciences teams can store raw and processed data in S3, query across datasets with Athena, build models with SageMaker, and manage access with IAM and Lake Formation.
That matters because many organizations already run research, analytics, and infrastructure workflows in AWS. Keeping omics workflows inside the same cloud architecture can simplify governance, reduce handoff friction, and make it easier to align data access with internal security and compliance requirements.
Why AWS-native architecture matters for life sciences
Life sciences organizations often face a choice between adopting third-party platforms or building more directly within AWS. The AWS-native path can offer better control over storage, compute, governance, and security, especially for teams that already have established cloud environments.
It can also help reduce platform layering and unnecessary cost markups. Instead of paying for additional abstraction where it is not needed, teams can keep more direct control over how data is stored, how workflows run, and how access is managed across research groups and locations.
Expected benefits for genomics and bioinformatics teams
When implemented well, Amazon Omics can improve collaboration between scientists, informaticians, and IT teams by reducing friction around workflow execution, data access, and infrastructure scaling. That can make bioinformatics pipelines more reproducible and easier to manage in regulated environments.
It also gives researchers more room to focus on data and discovery instead of backend configuration. For teams working across growing datasets and evolving workflows, that shift can make a meaningful difference in both speed and operational clarity.
How to get started with Amazon Omics
Some organizations will adopt Amazon Omics as part of a new AWS architecture, while others will integrate it into an existing research environment. In either case, the first step is understanding how current lab systems, data flows, and workflow requirements map to the service.
Teams should evaluate where data is coming from, how workflows are currently managed, what security and compliance requirements exist, and how much internal cloud maturity they already have. Those decisions shape whether Amazon Omics becomes a simple workflow improvement or a broader research platform foundation.
How PTP supports adoption
PTP helps life sciences organizations evaluate cloud readiness, align Amazon Omics with existing AWS environments, and support secure adoption across genomics and bioinformatics workflows. That can include architecture guidance, access design, compliance support, workflow planning, and ongoing cloud optimization.
For teams that want to move faster without losing governance, the goal is not simply to turn on a service. It is to make sure Amazon Omics fits the way research, IT, and data teams actually work.
Final takeaway
Amazon Omics gives life sciences organizations a more structured way to support genomic and multi-omic workflows in AWS. When paired with the right cloud architecture, governance model, and research workflow design, it can help teams improve scalability, reduce operational friction, and bring scientific data closer to real analysis and discovery.
Bring Omics to Life Faster
Ready to start using Amazon Omics for scalable, secure genomics workflows?